High-dose fractionated radiotherapy to 80 Gy for stage I-II medically inoperable non-small-cell lung cancer

High-dose fractionated radiotherapy to 80 Gy for stage I-II medically inoperable non-small-cell lung cancer

Introduction: Management of medically inoperable non‐small‐cell lung cancer (NSCLC) has been historically challenging, with poor rates of local control and disease‐specific survival. Nearly all published series of standard fractionation radiotherapy have utilised doses

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medical imaging and radiation oncology 2010-12, Vol.54 (6), p.554-561
Hauptverfasser: Watkins, JM, Wahlquist, AE, Zauls, AJ, Fields, EC, Garrett-Mayer, E, Aguero, EG, Silvestri, GA, Sharma, AK
Format: Artikel
Sprache:eng
Schlagworte:
Aged
Aged, 80 and over
Carcinoma, Non-Small-Cell Lung - pathology
Carcinoma, Non-Small-Cell Lung - radiotherapy
Disease-Free Survival
Female
Follow-Up Studies
Humans
Lung - pathology
Lung - radiation effects
Lung Neoplasms - pathology
Lung Neoplasms - radiotherapy
Male
medical inoperability
Middle Aged
Neoplasm Staging
non-small-cell lung cancer
radiotherapy
Radiotherapy Dosage
Retrospective Studies
Survival Analysis
Treatment Outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction: Management of medically inoperable non‐small‐cell lung cancer (NSCLC) has been historically challenging, with poor rates of local control and disease‐specific survival. Nearly all published series of standard fractionation radiotherapy have utilised doses
ISSN:1754-9477
1754-9485
DOI:10.1111/j.1754-9485.2010.02213.x